Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE]

NCT00445497 is registered in ClinicalTrials.gov with Clatterbridge Centre for Oncology as lead sponsor.

NCT NCT00445497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE]
Lead sponsor
Clatterbridge Centre for Oncology
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2007
Completion date
Not reported
Enrollment
400 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, lymphoma, neutropenia, psychosocial effects of cancer and its treatment, small intestine cancer, unspecified adult solid tumor, protocol specific